You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DORIPENEM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DORIPENEM

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00210938 ↗ Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed Peninsula Pharmaceuticals, Inc. Phase 3 2004-03-01 The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections.
NCT00210938 ↗ Doripenem in the Treatment of Complicated Intra-Abdominal Infections Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2004-03-01 The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections.
NCT00210990 ↗ Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed Peninsula Pharmaceuticals, Inc. Phase 3 2004-03-01 The purpose of this study is to assess the microbiological cure rate of doripenem in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis.
NCT00210990 ↗ Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2004-03-01 The purpose of this study is to assess the microbiological cure rate of doripenem in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis.
NCT00211003 ↗ Doripenem in the Treatment of Hospital-Acquired Pneumonia Completed Peninsula Pharmaceuticals, Inc. Phase 3 2004-05-01 The purpose of this study is to compare the safety and effectiveness of doripenem in patients with hospital-acquired pneumonia (HAP).
NCT00211003 ↗ Doripenem in the Treatment of Hospital-Acquired Pneumonia Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2004-05-01 The purpose of this study is to compare the safety and effectiveness of doripenem in patients with hospital-acquired pneumonia (HAP).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DORIPENEM

Condition Name

Condition Name for DORIPENEM
Intervention Trials
Urinary Tract Infections 5
Ventilator-Associated Pneumonia 5
Pneumonia 5
Pneumonia, Ventilator-Associated 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DORIPENEM
Intervention Trials
Infections 15
Infection 15
Communicable Diseases 13
Pneumonia 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DORIPENEM

Trials by Country

Trials by Country for DORIPENEM
Location Trials
United States 67
Argentina 7
Ukraine 6
Poland 5
Mexico 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DORIPENEM
Location Trials
Ohio 7
Michigan 7
California 6
District of Columbia 4
Arkansas 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DORIPENEM

Clinical Trial Phase

Clinical Trial Phase for DORIPENEM
Clinical Trial Phase Trials
Phase 4 7
Phase 3 13
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DORIPENEM
Clinical Trial Phase Trials
Completed 22
Terminated 5
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DORIPENEM

Sponsor Name

Sponsor Name for DORIPENEM
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 8
Peninsula Pharmaceuticals, Inc. 6
Janssen Research & Development, LLC 5
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DORIPENEM
Sponsor Trials
Industry 31
Other 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.